Infographic: Comprehensive genomic profiling assays for oncological studies
In this infographic, we explore how the next generation sequencing assay PanCancerIQTM can enhance precision oncology through supporting the identification of genomic alterations driving cancer growth, as well as identifying oncogenic driver events to predict treatment response and resistance.
This infographic is a part of our In the Zone feature with Eurofins Viracor (KS, USA) on clinical development for oncology. For more expert opinions on this topic, visit our feature homepage
BZ Eurofins-Viracor In the Zone Q2 INFOGRAPHIC (1)_compressed
[Illustrated by Tobias Dumbraveanu]
In association with:
